We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't cause classical G protein signaling and isn't modulated by the classical prescription or analgesic opioids, for example morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Instead, we proven that LIH383, an ACKR3-selective subnanomolar competitor peptide, https://lorenzt062qyf9.homewikia.com/user